176 related articles for article (PubMed ID: 38429254)
1. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
Chen L; Lin W; Zhang H; Geng S; Le Z; Wan F; Huang Q; Chen H; Liu X; Lu JJ; Kong L
Cell Death Dis; 2024 Mar; 15(3):178. PubMed ID: 38429254
[TBL] [Abstract][Full Text] [Related]
2. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.
Hong B; Zhou J; Ma K; Zhang J; Xie H; Zhang K; Li L; Cai L; Zhang N; Zhang Z; Gong K
Int J Biol Sci; 2019; 15(3):587-597. PubMed ID: 30745845
[TBL] [Abstract][Full Text] [Related]
3. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
[TBL] [Abstract][Full Text] [Related]
4. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
5. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
Zhang XW; Zhou JC; Peng D; Hua F; Li K; Yu JJ; Lv XX; Cui B; Liu SS; Yu JM; Wang F; Jin CC; Yang ZN; Zhao CX; Hou XY; Huang B; Hu ZW
Autophagy; 2020 May; 16(5):782-796. PubMed ID: 31286822
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
Örd T; Örd D; Adler P; Vilo J; Örd T
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
[TBL] [Abstract][Full Text] [Related]
7. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
Bao XY; Sun M; Peng TT; Han DM
Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
[TBL] [Abstract][Full Text] [Related]
8. TRIB3 confers glioma cell stemness via interacting with β-catenin.
Lu Y; Li L; Chen L; Gao Y; Chen X; Cao Y
Environ Toxicol; 2020 Jun; 35(6):697-706. PubMed ID: 31995275
[TBL] [Abstract][Full Text] [Related]
9. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
10. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
Liu C; Zhang W; Wang J; Si T; Xing W
Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
[TBL] [Abstract][Full Text] [Related]
12. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
13. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
14. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
15. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation.
Salazar M; Lorente M; García-Taboada E; Pérez Gómez E; Dávila D; Zúñiga-García P; María Flores J; Rodríguez A; Hegedus Z; Mosén-Ansorena D; Aransay AM; Hernández-Tiedra S; López-Valero I; Quintanilla M; Sánchez C; Iovanna JL; Dusetti N; Guzmán M; Francis SE; Carracedo A; Kiss-Toth E; Velasco G
Cell Death Differ; 2015 Jan; 22(1):131-44. PubMed ID: 25168244
[TBL] [Abstract][Full Text] [Related]
16. TRIB3 promotes lung cancer progression by activating β-catenin signaling.
Zhang X; Zhong N; Li X; Chen MB
Eur J Pharmacol; 2019 Nov; 863():172697. PubMed ID: 31562867
[TBL] [Abstract][Full Text] [Related]
17. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
18. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
Mondal D; Mathur A; Chandra PK
Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Pseudokinase TRIB3 in Normal Physiology and Disease: Charting the Progress in Old and New Avenues.
Ord T; Ord T
Curr Protein Pept Sci; 2017; 18(8):819-842. PubMed ID: 28393700
[TBL] [Abstract][Full Text] [Related]
20. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4α stability.
Xiao MC; Jiang N; Chen LL; Liu F; Liu SQ; Ding CH; Wu SH; Wang KQ; Luo YY; Peng Y; Yan FZ; Zhang X; Qian H; Xie WF
J Hepatol; 2024 May; 80(5):778-791. PubMed ID: 38237865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
